Clinical Research Directory
Browse clinical research sites, groups, and studies.
Remote Robotic Surgery for Gynecologic Cancer: A Safety and Effectiveness Study
Sponsor: Women's Hospital School Of Medicine Zhejiang University
Summary
This investigator-initiated, multicenter, single-blind, randomized controlled clinical study is designed to evaluate the safety and effectiveness of the MP2000 thoracoabdominal endoscopic surgical system (Shenzhen Jingfeng Medical Technology Co., Ltd.) when used for remote robotic surgery in patients with gynecologic malignancies. By comparing remote robotic surgery with local robotic surgery, the study will assess clinical outcomes including postoperative recovery, the incidence of complications, and the length of hospital stay, thereby providing clinical evidence on the safety and efficacy of remote robotic surgery versus conventional local robotic surgery.
Official title: A Multicenter, Single-Blind, Randomized Controlled Study on the Safety and Efficacy of Remote Robotic Surgery for Gynecologic Malignancies
Key Details
Gender
FEMALE
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
92
Start Date
2026-10-01
Completion Date
2029-09-01
Last Updated
2026-10-27
Healthy Volunteers
No
Interventions
MP2000 Thoracoabdominal Endoscopic Surgical System
The MP2000 is a thoracoabdominal endoscopic surgical system developed by Shenzhen Jingfeng Medical Technology Co., Ltd. It is a robotic surgical system used to perform minimally invasive surgery for gynecologic malignancies, including endometrial cancer and cervical cancer. In this study, it will be used for both remote robotic surgery (experimental group) and conventional local robotic surgery (control group).